The Effect of SGLT2 inhibitors on blood glucose variability in patients with type 1 diabetes
Not Applicable
- Conditions
- type 1 diabetes mellitus
- Registration Number
- JPRN-UMIN000039361
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who were thought to be inappropriate to enter this study for some reasons by physician's judgments
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in day-to-day and daily blood glucose variability
- Secondary Outcome Measures
Name Time Method 1 Blood and urine test (HbA1c, UACR, etc) 2 Body weight, Body mass index 3 Blood pressure 4 insulin dose 5 Adverse events